Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethel D Weld

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 13, 2018
Interest of Youth Living With HIV in Long-Acting AntiretroviralsEthel D Weld, Md Sohel Rana, Ronald H Dallas, et al.
AIDS Research and Therapy|May 22, 2024
Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysisSandra Abdul Massih, Mohamed G Atta, Chloe L Thio, et al.
AIDS Research and Human Retroviruses|November 9, 2016
A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and AcceptabilityEthel D Weld, Hiwot Hiruy, Kate Morrow Guthrie, et al.
AIDS Research and Therapy|November 26, 2022
Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case seriesChristin Kilcrease, Hasiya Yusuf, Joan Park, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and RegulationMoherndran Archary, Robert Bies, Osei Boateng, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxisJafar Sadik Shaik, Ethel D Weld, Stacey Edick, et al.
AIDS Research and Human Retroviruses|December 29, 2020
Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human StudyAmer Al-Khouja, Eugenie Shieh, Edward J Fuchs, et al.
Frontiers in Cellular and Infection Microbiology|September 27, 2019
Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota TransplantKevin DeLong, Sabrine Bensouda, Fareeha Zulfiqar, et al.
The Lancet. HIV|May 11, 2025
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trialEthel D Weld, Trevor Beattie, Jayajothi Moodley, et al.
Journal of Viral Hepatitis|March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakersNeil Gupta, Susan Swindells, Kimberly K Scarsi, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|November 13, 2018
Interest of Youth Living With HIV in Long-Acting AntiretroviralsEthel D Weld, Md Sohel Rana, Ronald H Dallas, et al.
AIDS Research and Therapy|May 22, 2024
Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysisSandra Abdul Massih, Mohamed G Atta, Chloe L Thio, et al.
AIDS Research and Human Retroviruses|November 9, 2016
A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and AcceptabilityEthel D Weld, Hiwot Hiruy, Kate Morrow Guthrie, et al.
AIDS Research and Therapy|November 26, 2022
Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case seriesChristin Kilcrease, Hasiya Yusuf, Joan Park, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and RegulationMoherndran Archary, Robert Bies, Osei Boateng, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxisJafar Sadik Shaik, Ethel D Weld, Stacey Edick, et al.
AIDS Research and Human Retroviruses|December 29, 2020
Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human StudyAmer Al-Khouja, Eugenie Shieh, Edward J Fuchs, et al.
Frontiers in Cellular and Infection Microbiology|September 27, 2019
Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota TransplantKevin DeLong, Sabrine Bensouda, Fareeha Zulfiqar, et al.
The Lancet. HIV|May 11, 2025
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trialEthel D Weld, Trevor Beattie, Jayajothi Moodley, et al.
Journal of Viral Hepatitis|March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakersNeil Gupta, Susan Swindells, Kimberly K Scarsi, et al.
Pageof 4